Protein drugs, recombinant vaccines and cell therapy are among the fastest growing products in the biotech industry. It is important to ensure quality and safety of emerging biopharmaceutical or cellular products in addition to their efficacy. The mission of our group is to offer a consolidated testing service with the following features: 1. Global quality standards: International Conference on Harmonization (ICH), United States Food and Drug Administration (FDA), European Medicines Agency (EMEA) etc. 2. GLP quality systems: Compliance with GLP (Taiwan, FDA & OECD); Audit by qualified QA personnel for critical steps and procedures during each study 3. Quick response and timely delivery 4. Availability of customization
Wang, Sih-Rong
Reseacher Ph.D. National Tsing Hua UniversityChang, Jen-Ting
QA Director M.S. National Taiwan UniversityShih, Hsiao-Ling
TD Director M.S. Da-Yeh UniversityShen, Chiu-Wen
Quality Assurance M.S. National Chung Hsing UniversityChen, Pei-Ying
Group Member M.S. National Chung Hsing UniversityChen, Wei-Jie
Group Member M.S. National Chiao Tung UniversityChen, Yi-Chun
Archivist B.S. National Chin-Yi University of TechnologyHuang, Cheih-Wen
Group Member M.S. National Chung Hsing UniversityWu, Li-Ting
Group Member M.S. National Cheng Kung UniversityDeng, Yu-Chiao
Group Member M.S. National Chiayi UniversityChung, Hui-yu
Group Member M.S. National Chiao Tung University